148 related articles for article (PubMed ID: 15684177)
21. Menostar - a low-dose estrogen patch for osteoporosis.
Med Lett Drugs Ther; 2004 Aug; 46(1190):69-70. PubMed ID: 15375352
[No Abstract] [Full Text] [Related]
22. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
Sharifi M; Lewiecki EM
Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
[TBL] [Abstract][Full Text] [Related]
24. Measurement of bone mineral density (BMD) with quantitative computed tomography (QCT) in postmenopausal osteoporosis: effect of estrogen.
Zgliczyński S; Szulc P; Słowińska-Srzednicka J; Stopińska-Głuszak U; Misiorowski W; Jeske W; Snochowska H; Wagiel K; Walecki J
Endokrynol Pol; 1992; 43(3):350-7. PubMed ID: 1345576
[TBL] [Abstract][Full Text] [Related]
25. Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis?
Schwartz K; Chang SI
J Fam Pract; 2001 Dec; 50(12):1024-5. PubMed ID: 11742601
[No Abstract] [Full Text] [Related]
26. Fracture prevention in postmenopausal women.
Bruyere O; Reginster JY
Clin Evid; 2002 Jun; (7):979-82. PubMed ID: 12230720
[No Abstract] [Full Text] [Related]
27. Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.
Reid IR; Cundy T; Grey AB; Horne A; Clearwater J; Ames R; Orr-Walker BJ; Wu F; Evans MC; Gamble GD; King A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2446-52. PubMed ID: 17440020
[TBL] [Abstract][Full Text] [Related]
28. Medications for postmenopausal osteoporosis prevention.
Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
[No Abstract] [Full Text] [Related]
29. Effective strategies to identify postmenopausal women at risk for osteoporosis.
Levine JP
Geriatrics; 2007 Nov; 62(11):22-30. PubMed ID: 17999567
[TBL] [Abstract][Full Text] [Related]
30. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
Groh KW; Stevermer JJ
J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
[No Abstract] [Full Text] [Related]
31. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and osteoporosis.
Drury R
Ir Med J; 1997 Oct; 90(6):214, 216. PubMed ID: 9611918
[No Abstract] [Full Text] [Related]
33. [Treatment of osteoporosis by the gynecologist].
Schneider HP; Dören M
Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
[TBL] [Abstract][Full Text] [Related]
34. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
35. Postmenopausal estrogen and the risk of breast cancer. The need for randomized trials.
Rossouw JE; Harlan WR
Ann Epidemiol; 1994 May; 4(3):255-6. PubMed ID: 8055127
[No Abstract] [Full Text] [Related]
36. Improved strategies for diagnosis and treatment of osteoporosis.
Epstein S; Goodman GR
Menopause; 1999; 6(3):242-50. PubMed ID: 10486795
[TBL] [Abstract][Full Text] [Related]
37. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
38. New low-dose estrogen approved for prevention of postmenopausal osteoporosis.
AWHONN Lifelines; 2003; 7(5):457-8. PubMed ID: 14710717
[No Abstract] [Full Text] [Related]
39. [Treatment of osteoporosis].
Salmi J; Välimäki M
Duodecim; 1996; 112(22):2131-8. PubMed ID: 10605219
[No Abstract] [Full Text] [Related]
40. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
